While stem cell research is ongoing, Hematology Specialist Prof. Dr. said, “Years have passed, we are still saying the same thing; it will work in the future. If used correctly, it can work in some diseases, there are still groups that believe in stem cells a lot, there should be, but as the person who is trying the most, I say that it should stop being the big hope. when I produced the stem cell in 1999, there were no more believers than me, but it’s not that capable. There are models where cell and gene therapy are used together, they will be even more successful,” he said.

Many studies are underway on stem cell therapy, which is indicated as a treatment used to regenerate a patient’s damaged cells, tissues and organs by transplanting stem cells taken from a person’s own or another (donor) to a sick person. While research on stem cells is continuing, he is a Member of the Board of Directors of the Stem Cell and Cellular Therapies Association, Hematology Specialist Prof. Dr. made statements about stem cell therapy in Turkey.


Hematology Specialist Prof. who started his remarks by stating that important studies were carried out in the field of stem cells in the 1998s. Dr. said, “We are still saying the same thing; it will work in the future. On the way we have come today, we have to talk more sensibly now. When used correctly, in the right indications and at the right doses, it can work for some diseases, but there is still no cell that regenerates life. Therefore, we can discuss this where stem cells are used correctly, there is a place, but I think it should stop being the great hope now. It’s just one of the existing cells. After the last 20 years, my perspective on stem cells has changed a little more. More specific, more mature cells are more differentiated, it is more important to use cells that know their job today. For example, in the treatment of cancer that saves people’s lives, malignant melanoma, leukemia, lymphoma, there are life-saving cells in question,” he said.


Prof., who said that he does not maintain his past belief in stem cell therapy. Dr. continued his words as follows:

Stem cells are a good cell to slow down the destruction, reduce inflammation in cases that go through inflammation, chronic destruction, can be used for this purpose. ’If I give it, I will deconstruct the heart, brain, liver’ unfortunately, this is still not a fact after 25 years that have passed. Science will be discussed, 2 different opinions will fight, eventually a synthesis will come out. Then the antisynthesis of that synthesis will also come out, this is science. Therefore, my experience is that I am the first person to produce stem cells in Turkey. when I produced a stem cell in 1999, when I told the whole of Turkey how to produce it in 2003, there was no one who believed in stem cells more than me at that time. After all these years of experience, I’m saying; he can still do important work in certain places, but don’t put too many tasks on him, he’s not that talented. We used to rely on an immature cell that we called a stem cell. Now it is mature, that is, it has been specified for a job, to do this job, taking the cells that function in the body and using them for that purpose now gives more accurate results. Cell therapy was approved for 3-4 diseases at one time and pushed aside all drugs. All of the cells that have received approval are mature; mature, knowledgeable cells. Therefore, we will be more successful if we use cells that know their job. There are still groups that believe in stem cells a lot, think that they are doing great things, I think it should be, and the other side should definitely be. We must fight and thus the right path must be found, but as the person who is trying the most, I do not keep my old faith in stem cells.”


Speaking about cancer treatment, Prof. Dr. said, “One is Car T Cell, the second is TIL (Lymphocytes that infiltrate the tumor), which we call 2 groups of things, I think, displace stones in cancer. These 2 treatments are also a treatment that displaces stones in the treatment of cancer. Car T Cell has already proven its success. TIL, on the other hand, has proven its success in malignant melanoma. Now the breast, lung, large intestine and pancreas are coming, we will wait for the results together. Cellular therapy is getting bigger and bigger, but its style is starting to change. And also models in which gene therapy is used together with the cell

Yes, they will be even more successful,” he said.

“I say it’s not going to work, he says, ’Fine, I want to try,’ it’s because of the wrong social media ads.”

Patients may have treatment requests based on sensations, Prof. Dr. said, “Patient-based advertising has started to spread a lot, when you enter social media, you see ads for products, doctors, this is an important problem. So that cellular therapy can find its true place, so that it can get to the place it deserves, now it is in a slightly mediatic position. I begged the patient, believe me, it won’t work, don’t do it, the cost of that treatment is 500 thousand TL. He will give half a million money and I say, it won’t work, but he says, ‘Well, I want to try,’ that’s because of these false social media medical ads,” he said.



Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.


Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.


Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.


Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me
Latest posts by Medically Reviewed by Professor Doctor Alper Demirbaş (see all)